Almoosa Health Company (TADAWUL:4018)
Saudi Arabia
· Delayed Price · Currency is SAR
165.20
+0.20 (0.12%)
Apr 17, 2025, 3:18 PM AST
Almoosa Health Company Ratios and Metrics
Market cap in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
Apr '25 Apr 17, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Debt / Equity Ratio | 1.89 | 1.89 | 1.86 | 1.23 | 0.86 | 0.59 |
Debt / EBITDA Ratio | 5.13 | 5.13 | 6.46 | 7.07 | 5.39 | 2.67 |
Asset Turnover | 0.50 | 0.50 | 0.47 | 0.48 | 0.50 | - |
Inventory Turnover | 13.07 | 13.07 | 12.33 | 11.76 | 10.58 | - |
Quick Ratio | 0.93 | 0.93 | 0.95 | 0.82 | 0.76 | 1.22 |
Current Ratio | 1.11 | 1.11 | 1.12 | 0.99 | 0.95 | 1.44 |
Return on Equity (ROE) | 13.75% | 13.75% | 15.05% | 8.19% | 10.51% | - |
Return on Assets (ROA) | 4.69% | 4.69% | 3.76% | 2.06% | 2.98% | - |
Return on Capital (ROIC) | 5.77% | 5.77% | 4.67% | 2.72% | 4.08% | - |
Return on Capital Employed (ROCE) | 9.10% | 9.10% | 6.80% | 3.90% | 5.80% | 10.80% |
Payout Ratio | 1483.58% | 14.84% | - | - | 25.09% | - |
Buyback Yield / Dilution | - | - | - | -34900.00% | - | - |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.